Head of Epidemiology
Medicines and Healthcare products Regulatory Agency
London, United Kingdom
Following a PhD in statistics, Katherine spent nearly four years with the Medical Research Council Clinical trials unit working in observational and interventional HIV treatment studies before moving to be a pharmacoepidemiologist at the Medicines and Healthcare products Regulatory Agency in the UK. Having now been there over 13 years, Katherine leads their epidemiology team working closely with partners across the Agency to advise on the value of observational studies and to develop strategy on the use of real world data to support regulation. She has particulalr interests in the use of RWE to support pharmacovigilance, vaccines safety, and the role of observational data in evaluating the safety of medical devices.
Disclosure information not submitted.
Regulatory Pharmacoepidemiology
Wednesday, August 23, 2023
8:30 AM – 12:30 PM ADT
Town Hall: Global Regulatory Forum on Real-World Evidence; Sponsored by ISPE's RWE Collaborative SIG
Friday, August 25, 2023
8:15 AM – 10:00 AM ADT
Sharing is Caring? A Symposium on Code Sharing in Pharmacoepidemiology
Saturday, August 26, 2023
4:15 PM – 5:45 PM ADT